COMPOSITION LIQUIDE POUR SON UTILISATION COMME SOLUTION NASALE

Patent europeic · EP3389629 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3389629
Numer da la dumonda
EP15834751
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-12-2015
Publitgà
24-10-2018
Concedì
21-04-2021
Stritgà
23-07-2022
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 9/00 (2006.01)
A61K 35/644 (2015.01)
A61P 39/00 (2006.01)
A61K 47/36 (2006.01)
A61K 9/08 (2006.01)
A61K 47/26 (2006.01)
Dumonda PCT
PCT/FR2015/053592 17.12.2015
Publicaziun PCT
WO2017/103348 22.06.2017
Lingua da l’annunzia
franzos
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.07.2022

  2. 02-03-2022

    Midada

    Published in Swissreg on 02.03.2022

  3. 21-04-2021

    Concedì

    Published in Swissreg on 21.04.2021

Partidas

Possessur

Hcp Healthcare Asia Pte.Ltd

3 Biopolis Drive No.01-13/14 Synapse, Singapore 138623, SG

URGO RECHERCHE INNOVATION ET DEVELOPPEMENT

Urgo Recherche Innovation et Développement

42, rue de Longvic, 21300 Chenove, FR

Inventur

DERAIN, Nathalie

21370 Prenois, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.